Whey, once a low-value byproduct of cheesemaking that was often fed to pigs or spread on fields, is now a highly profitable product. Modern cheese plants are designed specifically to harvest and process whey into high-demand whey protein isolates, fundamentally changing the business model of cheese production.

Whey, the primary ingredient in many protein supplements, was once a toxic waste product from cheese production. To avoid environmental penalties, the agri-food industry developed a process to transform this "garbage" into a profitable nutritional supplement, creating a lucrative new revenue stream.

Weight-loss drugs like Ozempic have moved from a niche medical treatment to a mainstream phenomenon, with new data showing 15.2% of all American women are now taking them. This rapid, large-scale adoption signifies a major public health shift that will have downstream effects on the food, fitness, and healthcare industries.

The widespread adoption of GLP-1 drugs for obesity, projected to reach 25 million U.S. users, will significantly reduce food, soda, and alcohol consumption. This presents a material, long-term revenue threat to consumer-facing industries like fast food, snack companies, and even casinos, forcing investors in those sectors to adjust their models.

Contrary to the narrative of decline, overall U.S. dairy consumption per capita is at its highest level in 40 years. While fluid milk consumption has dropped, this is more than offset by the booming popularity of value-added products like cheese, Greek yogurt, and cottage cheese.

The widespread adoption of GLP-1 therapies is projected to decrease total U.S. calorie consumption by 1.6% by 2035. This second-order effect will create significant disruption and headwinds for industries reliant on consumer food purchasing, including the CPG, retail, and restaurant sectors.

Andrew Huberman predicts GLP-1 drugs, accessed via compounding pharmacies and gray markets, will become so ubiquitous that being a healthy weight will no longer signal extreme discipline. This mirrors how auto loans and leases made luxury cars accessible to the masses, changing their social signaling value.

Drugs like Ozempic shift consumer preference from simple carbs to high-protein foods. This has accelerated beef demand, as users crave items like beef jerky over chips. This counterintuitive trend links pharmaceuticals to agricultural commodity markets.

The widespread use of GLP-1 drugs is forcing high-end restaurants to adapt to customers with suppressed appetites. They are creating new menus featuring tiny, high-quality portions at premium prices, catering to diners who desire the luxury experience without the volume of food.